Newbridge Financial Services Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52K | Hold |
1,200
| – | – | ﹤0.01% | 1042 |
|
|
2025
Q1 | $5.44K | Hold |
1,200
| – | – | ﹤0.01% | 788 |
|
|
2024
Q4 | $8.48K | Hold |
1,200
| – | – | ﹤0.01% | 768 |
|
|
2024
Q3 | $9.77K | Hold |
1,200
| – | – | ﹤0.01% | 433 |
|
|
2024
Q2 | $7.67K | Hold |
1,200
| – | – | ﹤0.01% | 759 |
|
|
2024
Q1 | $9.04K | Hold |
1,200
| – | – | ﹤0.01% | 794 |
|
|
2023
Q4 | $11.1K | Sell |
1,200
-34
| -3% | -$315 | 0.01% | 713 |
|
|
2023
Q3 | $12.5K | Hold |
1,234
| – | – | 0.01% | 762 |
|
|
2023
Q2 | $15.4K | Hold |
1,234
| – | – | 0.01% | 775 |
|
|
2023
Q1 | $14.4K | Hold |
1,234
| – | – | 0.01% | 821 |
|
|
2022
Q4 | $13.1K | Hold |
1,234
| – | – | 0.01% | 844 |
|
|
2022
Q3 | $12K | Buy |
1,234
+1,200
| +3,529% | +$11.7K | 0.01% | 836 |
|
|
2022
Q2 | $0 | Hold |
34
| – | – | ﹤0.01% | 1422 |
|
|
2022
Q1 | $1K | Hold |
34
| – | – | ﹤0.01% | 1377 |
|
|
2021
Q4 | $1K | Hold |
34
| – | – | ﹤0.01% | 1327 |
|
|
2021
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 1177 |
|
|
2021
Q2 | $2K | Hold |
34
| – | – | ﹤0.01% | 1274 |
|
|
2021
Q1 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 1170 |
|